Psilocybin FCR Early-Stage Breast Cancer

Clinical trial registration, sponsored by NYU Langone Health, registered 2 Nov 2026.

Phase 2 · not yet recruiting · n = 100

Tags: Registry, Psilocybin, Depression, Anxiety, Cancer.

Weekly Science Digest, 30 Oct 2026 to 5 Nov 2026, finding 6: In the clinic

Newly registered at NYU: psilocybin-assisted psychotherapy for fear of recurrence in early-stage breast cancer, 25 mg versus 5 mg active placebo

How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)

Read the original

—
Node—
Statuslive
Throughput—